Actavis to buy Allergan for $66 billion - FirstWord Pharma
  FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases - Global Competition Review
  Actavis - The Pharma Letter
  Teva Pharma EAD (formerly known as Actavis EAD) - SeeNews
  Little-known makers of generic drugs played central role in opioid crisis, records show - The Washington Post
  Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries - PR Newswire
  CMA wins drug market sharing appeal - GOV.UK
  Actavis's Brent Saunders Is Pharma's Best-Looking CEO - Institutional Investor